Pub Date : 2026-01-12DOI: 10.1080/10286020.2025.2611910
Marjan Shabazi, Seifollah Bahramikia, Razieh Kooshki
This study evaluated the potential of methyl jasmonate (MeJA) to modulate oxidative stress damage and hyperglycemia in rats with STZ-induced diabetes. MeJA treatment (5 and 10 mg/kg) improved the destructive effects of STZ-induced oxidative damage, as proved by the decline in ROS formation and lipid peroxidation. In addition, MeJA displayed a substantial upsurge in the level of tissue GSH and activity of CAT and SOD enzymes. Histological analysis confirmed MeJA alleviated liver damage. Given the crucial part oxidative stress plays in the etiology of diabetes, this study offers a novel viewpoint on MeJA's potential as a treatment.
{"title":"Methyl jasmonate protects liver and pancreas tissues of adult diabetic rats from STZ-induced oxidative stress damage.","authors":"Marjan Shabazi, Seifollah Bahramikia, Razieh Kooshki","doi":"10.1080/10286020.2025.2611910","DOIUrl":"https://doi.org/10.1080/10286020.2025.2611910","url":null,"abstract":"<p><p>This study evaluated the potential of methyl jasmonate (MeJA) to modulate oxidative stress damage and hyperglycemia in rats with STZ-induced diabetes. MeJA treatment (5 and 10 mg/kg) improved the destructive effects of STZ-induced oxidative damage, as proved by the decline in ROS formation and lipid peroxidation. In addition, MeJA displayed a substantial upsurge in the level of tissue GSH and activity of CAT and SOD enzymes. Histological analysis confirmed MeJA alleviated liver damage. Given the crucial part oxidative stress plays in the etiology of diabetes, this study offers a novel viewpoint on MeJA's potential as a treatment.</p>","PeriodicalId":15180,"journal":{"name":"Journal of Asian Natural Products Research","volume":" ","pages":"1-15"},"PeriodicalIF":1.3,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145952170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study investigates the therapeutic effects and mechanisms of the Yiqi Huoxue Recipe (YHR) on renal injury in Diabetic nephropathy (DN). Through mass spectrometry analysis, animal experiments, and network pharmacology approaches, it was found that YHR can ameliorate renal function indicators and pathological changes in DN rats, and reduce cell apoptosis. Mechanistic studies indicate that YHR alleviates hyperglycemia-induced renal inflammation and damage by inhibiting the HIF-1 signaling pathway, thereby improving DN.
{"title":"Research on the effects and mechanisms of the Yiqi Huoxue Recipe in improving renal injury in diabetic nephropathy through the HIF-1 pathway.","authors":"Wen-Di Niu, Hao-Wei Liang, Lue Hong, Jin-Xing He, Jia-Hui Qian, Fei Pan, Zhi-Wei Xu, Hui Wang","doi":"10.1080/10286020.2025.2602695","DOIUrl":"https://doi.org/10.1080/10286020.2025.2602695","url":null,"abstract":"<p><p>This study investigates the therapeutic effects and mechanisms of the Yiqi Huoxue Recipe (YHR) on renal injury in Diabetic nephropathy (DN). Through mass spectrometry analysis, animal experiments, and network pharmacology approaches, it was found that YHR can ameliorate renal function indicators and pathological changes in DN rats, and reduce cell apoptosis. Mechanistic studies indicate that YHR alleviates hyperglycemia-induced renal inflammation and damage by inhibiting the HIF-1 signaling pathway, thereby improving DN.</p>","PeriodicalId":15180,"journal":{"name":"Journal of Asian Natural Products Research","volume":" ","pages":"1-25"},"PeriodicalIF":1.3,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145952268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-10DOI: 10.1080/10286020.2025.2606379
Jie Li, Ye-Ting Zhang, Yusuf Abudula, Zhang-Rong Hou, Zheng-Yi Shi, Xin-Ye Huang, Ming Chen, Xue-Qi Lan, Ju-Bao Zhang, Chang-Xing Qi, Yong-Hui Zhang
Two undescribed alkaloids, mecichorine (1) and talaropyrazine D (2), along with four known compounds were isolated from an endophytic fungus Penicillium sp. HZ-5. Their structures were elucidated from the spectroscopic data. Furthermore, the isolated compounds were tested for their immunosuppressive activity, and compound 1 showed moderate immunosuppressive activity on Con A-induced T-lymphocyte proliferation in vitro, with an IC50 value of 15.2 ± 0.3 µM, and the others showed no obvious activities up to 40 µM.
{"title":"Discovery of undescribed alkaloids with immunosuppressive activity from the endophytic fungus <i>Penicillium</i> sp. HZ-5.","authors":"Jie Li, Ye-Ting Zhang, Yusuf Abudula, Zhang-Rong Hou, Zheng-Yi Shi, Xin-Ye Huang, Ming Chen, Xue-Qi Lan, Ju-Bao Zhang, Chang-Xing Qi, Yong-Hui Zhang","doi":"10.1080/10286020.2025.2606379","DOIUrl":"https://doi.org/10.1080/10286020.2025.2606379","url":null,"abstract":"<p><p>Two undescribed alkaloids, mecichorine (<b>1</b>) and talaropyrazine D (<b>2</b>), along with four known compounds were isolated from an endophytic fungus <i>Penicillium</i> sp. HZ-5. Their structures were elucidated from the spectroscopic data. Furthermore, the isolated compounds were tested for their immunosuppressive activity, and compound <b>1</b> showed moderate immunosuppressive activity on Con A-induced T-lymphocyte proliferation <i>in vitro</i>, with an IC<sub>50</sub> value of 15.2 ± 0.3 <i>µ</i>M, and the others showed no obvious activities up to 40 <i>µ</i>M.</p>","PeriodicalId":15180,"journal":{"name":"Journal of Asian Natural Products Research","volume":" ","pages":"1-6"},"PeriodicalIF":1.3,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145948818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-09DOI: 10.1080/10286020.2025.2608810
Xin-Li Ma, Wan-Qi Zhang, Jing-Han Zhang, Gu Zhao, Xin-Yue Li, Ming-Hui Sun, Jie Zhou, Guo-Ru Shi, De-Quan Yu, Yan-Fei Liu
Two new iridoid glycosides, dasperosides A-B (1-2), together with two known analogues (3-4), were isolated from the air-dried roots of Dipsacus asper. Their structures were established from the spectroscopic data obtained and chemical evidence. Compounds 1-4 were tested for their cytotoxicity against six human tumor cell lines, hepatoprotective and anti-inflammatory activities.
{"title":"Two new iridoid glycosides from the roots of <i>Dipsacus asper</i>.","authors":"Xin-Li Ma, Wan-Qi Zhang, Jing-Han Zhang, Gu Zhao, Xin-Yue Li, Ming-Hui Sun, Jie Zhou, Guo-Ru Shi, De-Quan Yu, Yan-Fei Liu","doi":"10.1080/10286020.2025.2608810","DOIUrl":"https://doi.org/10.1080/10286020.2025.2608810","url":null,"abstract":"<p><p>Two new iridoid glycosides, dasperosides <b>A</b>-<b>B</b> (<b>1</b>-<b>2</b>), together with two known analogues (<b>3</b>-<b>4</b>), were isolated from the air-dried roots of <i>Dipsacus asper</i>. Their structures were established from the spectroscopic data obtained and chemical evidence. Compounds <b>1</b>-<b>4</b> were tested for their cytotoxicity against six human tumor cell lines, hepatoprotective and anti-inflammatory activities.</p>","PeriodicalId":15180,"journal":{"name":"Journal of Asian Natural Products Research","volume":" ","pages":"1-9"},"PeriodicalIF":1.3,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145933414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To control plant pathogen infections, we synthesized naringenin derivatives bearing selenocyanate moieties and assayed their antibacterial activity against Xanthomonas axonopodis pv. citri, Xanthomonas oryzae pv. oryzae, and Xanthomonas oryzae pv. oryzicola via the microbroth dilution method. Structures were confirmed by 1H NMR, 13C NMR and HRMS. Compounds 4a and 4b featuring ether substitution at the 7-hydroxyl of naringenin showed potent activity against X. axonopodis pv. citri (EC50: 0.33-0.38 μg/ml) and X. oryzae pv. Oryzicola (EC50: 0.36-0.75 μg/ml), while 5b and 8c outperformed chlorothalonil against X. oryzae pv. Oryzae (EC50: 1.05-1.42 μg/ml). This study provides valuable insights for developing novel plant disease control agents.
{"title":"Synthesis and antibacterial activity of naringenin derivatives containing selenocyanate moiety.","authors":"Zhi-Ping Liu, Mai-Xia Liu, Chun-Rui Cai, Chun-Fang Gan, Jian-Guo Cui, Yan-Min Huang","doi":"10.1080/10286020.2025.2611908","DOIUrl":"https://doi.org/10.1080/10286020.2025.2611908","url":null,"abstract":"<p><p>To control plant pathogen infections, we synthesized naringenin derivatives bearing selenocyanate moieties and assayed their antibacterial activity against <i>Xanthomonas axonopodis</i> pv<i>. citri</i>, <i>Xanthomonas oryzae</i> pv<i>. oryzae</i>, and <i>Xanthomonas oryzae</i> pv<i>. oryzicola via</i> the microbroth dilution method. Structures were confirmed by <sup>1</sup>H NMR, <sup>13</sup>C NMR and HRMS. Compounds <b>4a</b> and <b>4b</b> featuring ether substitution at the 7-hydroxyl of naringenin showed potent activity against <i>X. axonopodis</i> pv. <i>citri</i> (EC<sub>50</sub>: 0.33-0.38 μg/ml) and <i>X. oryzae</i> pv. <i>Oryzicola</i> (EC<sub>50</sub>: 0.36-0.75 μg/ml), while <b>5b</b> and <b>8c</b> outperformed chlorothalonil against <i>X. oryzae</i> pv. <i>Oryzae</i> (EC<sub>50</sub>: 1.05-1.42 μg/ml). This study provides valuable insights for developing novel plant disease control agents.</p>","PeriodicalId":15180,"journal":{"name":"Journal of Asian Natural Products Research","volume":" ","pages":"1-14"},"PeriodicalIF":1.3,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145933434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tibetan Medicine Triphala (THL), consisting of Emblica officinalis, Terminalia bellerica, and Terminalia chebula, is a traditional Tibetan remedy for diabetes mellitus (DM). This study investigated THL's pancreatic metabolomic effects and impacts on paracrine factors (glucagon, insulin, somatostatin, pancreatic polypeptide) in diabetic rats. Rats were divided into six groups, gavaged for 8 weeks, with weekly blood glucose/body weight monitoring. THL reduced serum glucagon, somatostatin, pancreatic polypeptide, elevated insulin, restored pancreatic β-cell function, downregulated α/δ/pp cell expressions, normalized 5 key differential metabolites, and modulated four core metabolic pathways, exerting antidiabetic effects.
{"title":"Immunohistochemical and metabolomic analysis of Tibetan medicine triphala in response to pancreatic tissues of diabetic rats.","authors":"Xue-Yan Li, Xiao-Mei Long, Tao Liu, Shuang Guo, Jian-Xing Gu, Fang-Fang Chen, Yi-Dan Fan, Hai-Peng Liu, Yuan Fan, Zhu-Sheng Tang","doi":"10.1080/10286020.2025.2607494","DOIUrl":"https://doi.org/10.1080/10286020.2025.2607494","url":null,"abstract":"<p><p>Tibetan Medicine Triphala (THL), consisting of Emblica officinalis, Terminalia bellerica, and Terminalia chebula, is a traditional Tibetan remedy for diabetes mellitus (DM). This study investigated THL's pancreatic metabolomic effects and impacts on paracrine factors (glucagon, insulin, somatostatin, pancreatic polypeptide) in diabetic rats. Rats were divided into six groups, gavaged for 8 weeks, with weekly blood glucose/body weight monitoring. THL reduced serum glucagon, somatostatin, pancreatic polypeptide, elevated insulin, restored pancreatic β-cell function, downregulated α/δ/pp cell expressions, normalized 5 key differential metabolites, and modulated four core metabolic pathways, exerting antidiabetic effects.</p>","PeriodicalId":15180,"journal":{"name":"Journal of Asian Natural Products Research","volume":" ","pages":"1-19"},"PeriodicalIF":1.3,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-06DOI: 10.1080/10286020.2025.2608814
Dong-Hao Lu, Fei-Yan Wu, Nan Zhou, Xia Zhang, Zhen-Hua Li, Song Wang, Min Song, Zi-Wei Li, Xiao-Qi Zhang
Two novel monoterpenoid quinoline alkaloids, tabernacatines A and B (1 and 2), and a new monoterpenoid indole alkaloid, tabernacatine C (3), along with three known alkaloids (4 - 6), were isolated from the twigs and leaves of Tabernaemontana divaricata. Their structures were elucidated based on UV, IR, HR-ESI-MS, NMR spectra analysis, X-ray diffraction, and ECD calculation methods. Compounds 1 - 6 were evaluated for their neuroprotective effects in glutamate-induced HT22 cells, and compounds 4-6 exhibited potent neuroprotective effects.
{"title":"New alkaloids from the twigs and leaves of <i>tabernaemontana divaricata</i> and their neuroprotective effects.","authors":"Dong-Hao Lu, Fei-Yan Wu, Nan Zhou, Xia Zhang, Zhen-Hua Li, Song Wang, Min Song, Zi-Wei Li, Xiao-Qi Zhang","doi":"10.1080/10286020.2025.2608814","DOIUrl":"https://doi.org/10.1080/10286020.2025.2608814","url":null,"abstract":"<p><p>Two novel monoterpenoid quinoline alkaloids, tabernacatines A and B (<b>1</b> and <b>2</b>), and a new monoterpenoid indole alkaloid, tabernacatine C (<b>3</b>), along with three known alkaloids (<b>4 </b>-<b> 6</b>), were isolated from the twigs and leaves of <i>Tabernaemontana divaricata</i>. Their structures were elucidated based on UV, IR, HR-ESI-MS, NMR spectra analysis, X-ray diffraction, and ECD calculation methods. Compounds <b>1 - 6</b> were evaluated for their neuroprotective effects in glutamate-induced HT22 cells, and compounds <b>4</b>-<b>6</b> exhibited potent neuroprotective effects.</p>","PeriodicalId":15180,"journal":{"name":"Journal of Asian Natural Products Research","volume":" ","pages":"1-9"},"PeriodicalIF":1.3,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-02DOI: 10.1080/10286020.2025.2488322
Hui Shu , Fang-Fei Liu , Feng-Yan Su , Qian Zhang , Yan Zhao , Wei Li , Jia-Hong Han , En-Bo Cai
Based on the regulation of β-anhydroicaritin on the stability of p16INK4a encoded by CDKN2A gene, nine novel triphenylphosphine derivatives targeting tumor cell mitochondria were synthesized. Compound 13 increased the ability to inhibit lung cancer A549 cells by 24 times compared with 5-fluorouracil. Biological studies have shown that compound 13 significantly promotes early apoptosis and induces mitochondrial dysfunction in A549 cells. Further studies showed that compound 13 arrested 73% of the cells in the G0/G1 phase, preventing the cells from entering the DNA synthesis phase. In summary, compound 13 is expected to be developed as a new targeted anti-tumor drug.
{"title":"Design and synthesis of a novel β-anhydroicartin derivative targeting tumor cell mitochondria based on the regulation of p16INK4a and its in vitro biological activity evaluation","authors":"Hui Shu , Fang-Fei Liu , Feng-Yan Su , Qian Zhang , Yan Zhao , Wei Li , Jia-Hong Han , En-Bo Cai","doi":"10.1080/10286020.2025.2488322","DOIUrl":"10.1080/10286020.2025.2488322","url":null,"abstract":"<div><div>Based on the regulation of β-anhydroicaritin on the stability of p16INK4a encoded by CDKN2A gene, nine novel triphenylphosphine derivatives targeting tumor cell mitochondria were synthesized. Compound <strong>13</strong> increased the ability to inhibit lung cancer A549 cells by 24 times compared with 5-fluorouracil. Biological studies have shown that compound <strong>13</strong> significantly promotes early apoptosis and induces mitochondrial dysfunction in A549 cells. Further studies showed that compound <strong>13</strong> arrested 73% of the cells in the G0/G1 phase, preventing the cells from entering the DNA synthesis phase. In summary, compound <strong>13</strong> is expected to be developed as a new targeted anti-tumor drug.</div></div>","PeriodicalId":15180,"journal":{"name":"Journal of Asian Natural Products Research","volume":"28 1","pages":"Pages 74-90"},"PeriodicalIF":1.3,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144018210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-02DOI: 10.1080/10286020.2025.2491612
Wei-Jie Li , Chong-Lian Feng , Zhao-Yuan Nie , Ling-Yun Li , Jian-Hui Guo , Xiang-Yu Liu , Yang-Hao Su , Shan-Shan Liu , Zhi-Zhong Cui
Mahuang Fuzi Xixin Decoction (MFX), a traditional Chinese medicine containing 44 volatile components (97.36% total oil), includes key compounds like α-terpenol (13.34%) and 1,2,3-trimethoxy-5-methyl-benzene (22.64%). Using network pharmacology and Mendelian randomization, 24 active compounds were identified targeting MS-related pathways (NF-κB, NLRP3, Toll-like receptor). Genetic variants in CYP450, GSK3B, CYBB, and PON1 correlated with reduced MS risk. In EAE mice, MFX decreased spinal GSK-3B expression (immunofluorescence) and pro-inflammatory factors (ELISA), demonstrating neuroprotection via anti-inflammatory, antioxidative mechanisms and restored GSK-3B levels, highlighting therapeutic potential for MS.
{"title":"A network pharmacological target mendelian randomization study on the neuroprotective effects of active ingredients in mahuang fuzi xixin decoction for multiple sclerosis","authors":"Wei-Jie Li , Chong-Lian Feng , Zhao-Yuan Nie , Ling-Yun Li , Jian-Hui Guo , Xiang-Yu Liu , Yang-Hao Su , Shan-Shan Liu , Zhi-Zhong Cui","doi":"10.1080/10286020.2025.2491612","DOIUrl":"10.1080/10286020.2025.2491612","url":null,"abstract":"<div><div>Mahuang Fuzi Xixin Decoction (MFX), a traditional Chinese medicine containing 44 volatile components (97.36% total oil), includes key compounds like α-terpenol (13.34%) and 1,2,3-trimethoxy-5-methyl-benzene (22.64%). Using network pharmacology and Mendelian randomization, 24 active compounds were identified targeting MS-related pathways (NF-κB, NLRP3, Toll-like receptor). Genetic variants in CYP450, GSK3B, CYBB, and PON1 correlated with reduced MS risk. In EAE mice, MFX decreased spinal GSK-3B expression (immunofluorescence) and pro-inflammatory factors (ELISA), demonstrating neuroprotection via anti-inflammatory, antioxidative mechanisms and restored GSK-3B levels, highlighting therapeutic potential for MS.</div></div>","PeriodicalId":15180,"journal":{"name":"Journal of Asian Natural Products Research","volume":"28 1","pages":"Pages 91-111"},"PeriodicalIF":1.3,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144025447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-02DOI: 10.1080/10286020.2025.2530748
Zheng-Hao Chen , Xin-De Li , Mei-Zhen Luo , Wu-Yu Mao , Shuai Huang , Xian-Li Zhou
Photodynamic therapy (PDT) is a promising non-invasive tumor treatment. Researchers study cell death mechanisms—apoptosis, necrosis, and autophagy—to improve photosensitizer design for precise tumor destruction while sparing normal tissue. This review summarizes these biological causes of cell death. It focuses on recent innovations in PDT drug development and therapeutic techniques, specifically detailing how photosensitizers kill cancer cells. The paper also highlights clinical challenges faced by therapies targeting these common mechanisms and the potential of novel mechanisms. It aims to provide new perspectives on tumor death mechanisms and PDT drug development, offering a basis for novel smart PDT systems.
{"title":"Advances in drug design strategies for phototherapy based on tumor cell death mechanisms","authors":"Zheng-Hao Chen , Xin-De Li , Mei-Zhen Luo , Wu-Yu Mao , Shuai Huang , Xian-Li Zhou","doi":"10.1080/10286020.2025.2530748","DOIUrl":"10.1080/10286020.2025.2530748","url":null,"abstract":"<div><div>Photodynamic therapy (PDT) is a promising non-invasive tumor treatment. Researchers study cell death mechanisms—apoptosis, necrosis, and autophagy—to improve photosensitizer design for precise tumor destruction while sparing normal tissue. This review summarizes these biological causes of cell death. It focuses on recent innovations in PDT drug development and therapeutic techniques, specifically detailing how photosensitizers kill cancer cells. The paper also highlights clinical challenges faced by therapies targeting these common mechanisms and the potential of novel mechanisms. It aims to provide new perspectives on tumor death mechanisms and PDT drug development, offering a basis for novel smart PDT systems.</div></div>","PeriodicalId":15180,"journal":{"name":"Journal of Asian Natural Products Research","volume":"28 1","pages":"Pages 1-33"},"PeriodicalIF":1.3,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144642656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}